← Leaderboards
Jaime Nmn Simon
Isotherapeutics Group, Llc
$1,634,379
Attributed
$1,634,379
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $701.8K · FY2010–15$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,634,379 · 2
By mechanism
R44$1,490,797 · 1
R43$143,582 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Event”
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Francis L Halzen · University Of Wisconsin-Madison$229,314,069
Research focus
EventHolmiumDistantDose-LimitingGenerationsBiodistributionAmerican Cancer SocietyBoneDosageDoseAdverse EffectsFundingBone NeoplasmsBone PainAreaCancer CellCanis FamiliarisCessation Of LifeAri Brand Of 153sm-EdtmpDisease-Free SurvivalBone Marrow NeoplasmsClinical TrialsConduct Clinical TrialsIn Situ
Grant awards (4)
A new radiopharmaceutical for the treatment of metastatic bone cancer$94,239
R44 · FY2015 · CA · contact PI
A new radiopharmaceutical for the treatment of metastatic bone cancer$701,849
R44 · FY2014 · CA · contact PI
A new radiopharmaceutical for the treatment of metastatic bone cancer$694,709
R44 · FY2013 · CA · contact PI
A new radiopharmaceutical for the treatment of metastatic bone cancer$143,582
R43 · FY2010 · CA · contact PI